To evaluate safety with the use of Systane Ultra in contact lens wearers. A comparison to a currently marketed contact lens rewetting drop will be included as a control.

Inclusion Criteria:

• Participants must be between 18 and 65 years of age.
• Provide written Informed Consent.
• Must be wearing a planned replacement soft lens in a 2 week or monthly replacement modality, or a Rigid Gas Permeable (RGP) contact Lens
• Must have best corrected distance visual acuity, with contact lenses, of 20/30 or better in each eye.
• Sodium fluorescein (NaFl) corneal staining score sum of < 2 in both eyes (NEI scoring system).
• Must be willing to maintain pre-enrollment systemic medication regimens during the study.
• Must be available for study visits and to fill out study questionnaires.

Exclusion Criteria:

• Has modified their systemic medications within 30 days prior to enrollment.
• Has a history of allergy to any study product ingredients
• Is unwilling or unable to meet the study visit timeline.
• Has any active corneal, eyelid or other anterior segment inflammation or infection, which, in the opinion of the Investigator, would adversely affect successful contact lens wear.
• Is currently using any topical eye medications (not including rewetting drops, artificial tear products or Restasis).

community sample